Citius Oncology, Inc.

CTOR·NASDAQ·$0.86Share Price as of 11/2·$80MMarket Cap as of 11/2

Financials

10-QQ3 ended 06/30/2608/14/26 10-QQ2 ended 03/31/2605/15/26 10-QQ1 ended 12/31/2502/13/26 10-KFY 202512/23/25 10-QQ3 ended 06/30/2508/12/25

Disclosures

8-KCurrent report10/26/26 8-KCurrent report10/23/26 8-KCurrent report09/29/26 8-KCurrent report08/14/26 8-KCurrent report08/12/26

Prospectuses and Registrations

424B3Prospectus08/14/26 424B3Prospectus08/05/26 424B3Prospectus06/01/26 S-3Shelf registration05/29/26 424B3Prospectus05/22/26

Proxies

DEF 14ADefinitive proxy08/26/26 DEF 14ADefinitive proxy09/26/25 DEFA14AAdditional proxy materials01/10/24 DEF 14ADefinitive proxy01/08/24 PRE 14APreliminary proxy12/28/23

Ownership

Form 3Initial insider ownership08/14/26 SC 13G/ABeneficial ownership (amended)08/14/26 SC 13D/ABeneficial ownership (amended)06/04/26 SC 13G/ABeneficial ownership (amended)05/15/26 SC 13G/ABeneficial ownership (amended)02/17/26

Other

ARSAnnual report to shareholders08/26/26 EFFECTRequest for effectiveness06/05/26 CORRESPCorrespondence with the SEC06/03/26 UPLOADLetter from the SEC06/03/26 DEF 14CDefinitive information statement05/29/26